Abstract
Ya-Ling Liu, Qing-Qing Xing, Xiang Lin, Wei-Wei Zeng, Yin-Hong Chen, Yan-Ying You, Li-Na Zhou, Xiao-Ning Chen, Min-Xia Wu, Han-Xin Xue, Shangeng Weng, Jin-Shui Pan
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and meta-analysis
10.1016/j.eclinm.2023.102280 · 2023
10.1111/jgh.15329
10.1111/jgh.15329
10.1136/bmj-2022-070201
10.1136/bmj-2022-070201
Global Epidemiology of Primary Biliary Cholangitis: An Updated Systematic Review and Meta-Analysis
10.1016/j.cgh.2025.03.025 · 2026
10.1136/gutjnl-2024-333171
10.1136/gutjnl-2024-333171
EASL Clinical Practice Guidelines on the management of autoimmune hepatitis
10.1016/j.jhep.2025.03.017 · 2025
10.1002/hep.30145
10.1002/hep.30145
10.1136/gutjnl-2017-315259
10.1136/gutjnl-2017-315259
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)
2023
The Possible Effects of Ursodeoxycholic Acid on Recurrent Primary Biliary Cholangitis and Biliary Complications After Liver Transplant
2021
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis
10.1016/j.jhep.2020.03.043 · 2020
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
10.1038/s41575-019-0226-7 · 2020
10.1016/s0140-6736(24)01303-5
10.1016/s0140-6736(24)01303-5
Autoimmune liver diseases in the Asia Pacific region: proceedings of the autoimmune liver disease course at APASL 2025
10.1007/s12072-025-10965-6 · 2026
10.1038/cmi.2018.7
10.1038/cmi.2018.7
Role of microbiome in autoimmune liver diseases
10.1097/hep.0000000000000506 · 2024
10.1136/gutjnl-2016-313332
10.1136/gutjnl-2016-313332
Gut microbiome pattern impacts treatment response in primary biliary cholangitis
10.1016/j.medj.2024.08.003 · 2025
10.1136/gutjnl-2018-317836
10.1136/gutjnl-2018-317836
Epidemiology and surveillance of autoimmune hepatitis in Asia
10.1111/liv.15155 · 2022
Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases
10.1016/j.autrev.2015.03.008 · 2015
Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome
2021
10.1016/j.jhep.2010.09.002
10.1016/j.jhep.2010.09.002
10.1002/hep.1840110106
10.1002/hep.1840110106
10.1053/jhep.2000.8090
10.1053/jhep.2000.8090
10.1038/s41467-018-04408-0
10.1038/s41467-018-04408-0
10.3390/microorganisms8071011
10.3390/microorganisms8071011
10.1172/jci108729
10.1172/jci108729
Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response
10.4049/jimmunol.159.1.3 · 1997
10.4049/jimmunol.1400076
10.4049/jimmunol.1400076
10.1001/archneur.64.5.683
10.1001/archneur.64.5.683
10.1093/rheumatology/35.6.568
10.1093/rheumatology/35.6.568
10.1210/jc.2009-0106
10.1210/jc.2009-0106
Immunological abnormalities in patients with primary biliary cholangitis
10.1042/cs20181123 · 2019
IL-15-producing splenic B cells play pathogenic roles in the development of autoimmune hepatitis
10.1016/j.jhepr.2023.100757 · 2023
Tfh and plasma cells are correlated with hypergammaglobulinaemia in patients with autoimmune hepatitis
10.1111/liv.12245 · 2014
10.1002/hep.27313
10.1002/hep.27313
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
10.1016/j.jhepr.2019.10.005 · 2019
10.1111/j.1365-2249.2009.03947.x
10.1111/j.1365-2249.2009.03947.x
Identification of a novel PDC-E2 epitope in primary biliary cholangitis: Application for engineered Treg therapy
10.1016/j.jaut.2024.103327 · 2024
No additional external references are available.